Kazia Therapeutics (Cantrixil) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Kazia Therapeutics (Cantrixil) General Information
Description
Portfolio of global development rights for Cantrixil. The asset is used for the treatment of ovarian cancer.
Contact Information
Corporate Office
- Uppsala
- Sweden
Corporate Office
- Uppsala
- Sweden
Kazia Therapeutics (Cantrixil) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kazia Therapeutics (Cantrixil) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kazia Therapeutics (Cantrixil) FAQs
-
Where is Kazia Therapeutics (Cantrixil) headquartered?
Kazia Therapeutics (Cantrixil) is headquartered in Uppsala, Sweden.
-
What industry is Kazia Therapeutics (Cantrixil) in?
Kazia Therapeutics (Cantrixil)’s primary industry is Buildings and Property.
-
Is Kazia Therapeutics (Cantrixil) a private or public company?
Kazia Therapeutics (Cantrixil) is a Private company.
-
What is the current valuation of Kazia Therapeutics (Cantrixil)?
The current valuation of Kazia Therapeutics (Cantrixil) is .
-
What is Kazia Therapeutics (Cantrixil)’s current revenue?
The current revenue for Kazia Therapeutics (Cantrixil) is .
-
Who are Kazia Therapeutics (Cantrixil)’s investors?
Kazia Therapeutics has invested in Kazia Therapeutics (Cantrixil).
-
When was Kazia Therapeutics (Cantrixil) acquired?
Kazia Therapeutics (Cantrixil) was acquired on 29-Mar-2021.
-
Who acquired Kazia Therapeutics (Cantrixil)?
Kazia Therapeutics (Cantrixil) was acquired by Vivesto.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process